Related Experiment Video

Updated: Aug 9, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

Hypertensive heart disease

Joseph A Diamond1, Robert A Phillips

  • 1Division of Cardiology, Long Island Jewish Hospital, New Hyde Park, New York 10040, USA. jdiamond@lij.edu

Hypertension Research : Official Journal of the Japanese Society of Hypertension
|August 16, 2005
PubMed

Insights

Hypertensive heart disease, marked by left ventricular hypertrophy (LVH) and diastolic dysfunction (CHF-D), increases cardiovascular risks. Antihypertensive therapy aims to lower blood pressure and reverse LVH to reduce these risks.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Medicine

Background:

  • Left ventricular hypertrophy (LVH) and diastolic dysfunction (CHF-D) are early indicators of cardiovascular damage in hypertension.
  • These conditions signify hypertensive heart disease, increasing risks for heart failure, arrhythmias, and myocardial infarction.
  • Identifying hypertensive heart disease is crucial for timely intervention and risk reduction.

Purpose of the Study:

  • To review current and emerging strategies for managing hypertensive heart disease.
  • To explore the pathophysiology of LVH and CHF-D in arterial hypertension.
  • To summarize therapeutic approaches targeting both blood pressure and BP-independent mechanisms.

Main Methods:

  • Literature review of current and emerging research on hypertensive heart disease.
  • Analysis of pathophysiological mechanisms driving left ventricular hypertrophy and diastolic dysfunction.
  • Synthesis of therapeutic interventions for blood pressure management and LVH regression.

Main Results:

  • Antihypertensive therapy can lead to regression of left ventricular mass.
  • Reducing LV mass is associated with decreased risk of future cardiovascular events.
  • Effective treatment requires addressing both blood pressure and underlying pathophysiological processes.

Conclusions:

  • Regression of LVH through antihypertensive treatment is a key goal.
  • Therapeutic strategies should encompass both BP reduction and modulation of BP-independent pathways.
  • Comprehensive management of hypertensive heart disease is vital for preventing adverse cardiovascular outcomes.

More Related Videos

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...